KMTS
KESTRA MEDICAL (KMTS)
NASDAQ
$22.85+$0.02 (+0.09%)
Price as of Aug 03, 2026 7:32 AM EDT
  • $1.3B
    Market Cap
  • 48.44%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
04/30/2026
04/30/2025
Income Statement
Total Operating Revenue
95.1M
+59.03%
59.8M
N/A
Cost of Revenue
46.3M
+29.93%
35.6M
N/A
Gross Profit
48.9M
+101.83%
24.2M
N/A
Sales and Marketing Expense
164.1M
+42.79%
114.9M
N/A
Research and Development Expense
-19.5M
+24.48%
-15.7M
N/A
Depreciation and Amortization Expense
8.7M
+9.30%
8.0M
N/A
Total Operating Expenses
183.6M
+40.60%
130.6M
N/A
Operating Profit
-134.7M
+26.66%
-106.4M
N/A
Interest Income
8.4M
+161.05%
3.2M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
8.4M
+161.05%
3.2M
N/A
Total Nonoperating Income and Expense
2.6M
+194.65%
-2.8M
N/A
Income before Taxes
-131.3M
+15.52%
-113.7M
N/A
Income Taxes
294,000
+117.78%
135,000
N/A
Extraordinary Items
N/A
N/A
0
N/A
Net Income
-131.6M
+15.64%
-113.8M
N/A
Net Income from Continuing Operations Applicable to Common
-131.6M
+4.34%
-126.1M
N/A
Basic EPS and Net Income
-2.43
-52.63%
-5.13
N/A
Diluted EPS and Net Income
-2.43
-52.63%
-5.13
N/A
Basic Weighted Average Shares
54.2M
+120.41%
24.6M
N/A
Diluted Weighted Average Shares
54.2M
+120.41%
24.6M
N/A
Balance Sheet
Cash and Cash Equivalents
20.0M
-91.58%
237.6M
N/A
Short-Term Investments
96.7M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
116.7M
-50.87%
237.6M
N/A
Total Current Assets
222.4M
-12.91%
255.3M
N/A
Accumulated Depreciation
31.4M
+31.19%
24.0M
N/A
Property and Plant and Equipment and Net
59.1M
+69.65%
34.8M
N/A
Total Long-Term Assets
5.8M
+402.17%
1.2M
N/A
Total Assets
358.5M
+21.21%
295.7M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
50.4M
+32.64%
38.0M
N/A
Total Long-Term Debt
42.6M
+3.77%
41.1M
N/A
Total Long-Term Liabilities
306,000
+118.57%
140,000
N/A
Total Liabilities
98.8M
+9.37%
90.3M
N/A
Retained Earnings
-651.9M
+25.30%
-520.2M
N/A
Total Stockholders Equity
259.7M
+26.41%
205.4M
N/A
Total Shares Outstanding
58.4M
+13.70%
51.3M
N/A
Cash Flow
Cash from Operating Activities
-81.7M
+5.28%
-77.6M
N/A
Capital Expenditures
34.9M
+52.13%
22.9M
N/A
Cash from Investing Activities
-203.3M
+772.13%
-23.3M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
147.1M
-55.46%
330.3M
N/A
Financials Ratio
Gross Margin
51.37%
N/A
N/A
N/A
Operating Margin
-141.64%
N/A
N/A
N/A
Return on Assets
-40.24%
N/A
N/A
N/A
Return on Equity
-56.60%
N/A
N/A
N/A
Revenue Growth
59.03%
N/A
N/A
N/A
Current Ratio
4.41
N/A
N/A
N/A
Cash Ratio
0.40
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow